Olamide Animasahun

Olamide Animasahun is a Researcher in the Department of Biomedical Engineering at the University of Michigan, affiliated with the Deepak Nagrath Lab. Their research focuses on metabolic pathways and their roles in cancer progression, therapy resistance, and precision medicine. Key areas include targeting metabolic vulnerabilities in tumors, leveraging extracellular vesicles for diagnostic and therapeutic applications, and integrating multi-omics approaches to identify novel therapeutic strategies.

Research interests emphasize oncology, particularly in triple-negative breast cancer, ovarian cancer, medulloblastoma, and biliary tract cancers. Projects explore mechanisms like cuproptosis induction, glutamine dependency, and collateral lethality in metabolic pathways. Innovations include biomaterial-based immunotherapies and microfluidic technologies for biomarker screening.

Publications highlight advancements in understanding metabolic reprogramming in tumors, biomarker discovery, and preclinical/clinical evaluations of combination therapies. The Nagrath Lab collaborates across disciplines to translate metabolic insights into clinical applications for cancer treatment and diagnosis.